This is a $2,495,629.45 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Deloitte Consulting LLP, a leading management and technology consulting firm, to identify and evaluate innovative strategies for retaining participants in the National Diabetes Prevention Program. The contract has an ultimate completion date of August 21, 2025. Deloitte has extensive experience supporting federal civilian agencies, including the CDC, through prime contracts and subcontracts. The contract does not have a set-aside designation. Deloitte holds several significant federal Indefinite Delivery Vehicle (IDV) contracts, including a $60.7 billion multiple-award IDIQ with the Department of Veterans Affairs, which allows the company to compete for task orders across the federal government.
Generated 1/16/25, 9:20 AM